From the Media

Home > From the Media

Vegetarian Meat (Hebrew)

ידיעות אחרונות, June 14, 2022

Joining forces to advance the food industry (Hebrew)

Technion Magazine, Summer 2022

Can you grow sustainable, delicious meat in a lab?

The David Suissa Podcast, May 13, 2022

Israeli companies at NASDAQ want to bring lab-grown meat to the masses

Jewish Telegraphic Agency, March 30, 2022

“Cell-Based, Innovative Products for a Better Future”
The Jerusalem Post, March 10, 2022

Biotech Serves Breakthrough Therapies, With A Side Of Cultured Meat

JewishPress.com, February 17, 2022

Israel’s Foodtech Convention (Hebrew)

Channel 12 Keshet, February 10, 2022

Israel’s biggest food maker enters JV to put ‘affordable cultured food on the table’

FoodNavigator.com, January 18, 2022

Israel’s Tnuva and Pluristem to Develop Cultured Cell-Based Meat
The Jerusalem Post, January 10, 2022
Tnuva and Pluristem Set Up Cultured Meat JV
Globes, January 10, 2022
A New Standard of International Conferences (Hebrew)

TheMarker, December 7, 2021

Key Considerations and Risk Management Best Practice for Placenta-Derived Cell Therapy Raw Materials 

Cell & Gene Therapy Insights, October 22, 2021

The 22 most interesting Israel-UAE agreements of the year

Israel21C, September 12, 2021

Israel: The ‘Start-Up Nation’ is now the ‘Biotech Nation’ – opinion

The Jerusalem Post, August 4, 2021

Analytical Methods for Cell Therapies: Method Development and Validation Challenges

BioProcess International, June 18, 2021

Pluristem CEO touts a new generation of medical treatments

Khaleejtimes, June 10, 2021

Pluristem Speaks at The Jerusalem Post’s Global Investment Forum 2021 in Dubai

June 9, 2021

Yaky Yanay, CEO de Pluristem : «Nous lançons des traitements médicaux de nouvelle génération»

L’Observateur du Maroc et de l’Afrique, June 4, 2021

Yaky Yanay : « La biotechnologie pourra sauver le monde des virus à venir

L’Observateur du Maroc et de l’Afrique, June 3, 2021

Advancing Tech, Medicine, and Togetherness at the Global Investment Forum

The Jerusalem Post, June 1, 2021

Global Investment Forum to turn UAE-Israel collaborations into reality

The Jerusalem Post, May 26, 2021

Israeli biotech leader calls for Arab-Jewish coexistence

Israel 21C, May 17, 2021

CEO Yaky Yanay at Geekonomy podcast (Hebrew)

May 5,2021

Pluristem’s placenta cells induce body to create new blood cells – study

The Jerusalem Post, May 02, 2021

Genesis Prize and Start-up Nation Central announce winners of the competition in honor of Natan Sharansky

The Genesis Prize, December 24, 2020

Interview with Dr. Racheli Ofir, VP Research & IP and Ein Mahel High School student about the educational biological experiment with (Hebrew)

Channel 12 Morning Show, December 04, 2020

Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges

Cell & Gene Therapy Insights, November 23, 2020

  Pluristem is ranked the 26th Best Hi-Tech company to work for in Israel in 2020 (Hebrew)

CALALIST, October 26, 2020

Coliseum Medical Centers in Macon testing potential COVID-19 treatment

13WMAZ, October 19, 2020

An Israeli company and a company from Abu Dhabi are developing an innovative treatment for Corona

KAN11, October 19, 2020

Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel

The New York Times, October 07, 2020

Israeli and Emirati companies join forces to develop COVID-19 treatment

The Jerusalem Post, October 02, 2020

Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event

The New York Times, October 01, 2020

Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Patient Treatment Outside of Clinical Trial

The New York Times, August 27, 2020

Israeli Pluristem will Cooperate with Abu Dhabi Medical Center (Hebrew)

ידיעות אחרונות, August 27, 2020

The first medical cooperation agreement between two companies – an Israeli and an Emirati (Arabic)

Bokra, August 20, 2020

Stem cell centres in UAE, Israel sign agreement

Khaleej Times, August 18, 2020

Cooperation between Israel and Abu Dhabi (Hebrew)

Israeli Channel 12, August 17, 2020

Israeli-based Pluristem and Abu Dhabi Stem Cells Center sign deal to collaborate in development of cell therapies

Calcalist, August 17, 2020

Will the cure come from the placenta? Pluristem will begin a Phase II study in Germany for COVID-19 patients (Hebrew)

Calcalist, August 10, 2020

Some potentially positive COVID news?

The Times of Israel, August 07, 2020

Broadway Set Designer Survives Covid-19 After 46 Days On Ventilator

The Tamron Hall Show, August 03, 2020

Supported by the European Investment Bank: The Israeli company trying to find treatment for COVID-19 (Hebrew)

Walla, July 26, 2020

Edward Pierce’s Miracle: How a Broadway Set Designer Beat Covid and Made Medical History

THEATERMANIA, June 25, 2020

Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year?

Yahoo Finance, June 01, 2020

Cell therapy’s role in defeating Covid-19

Cell & Gene Therapy Insights, May 27, 2020

Israel’s Pluristem: 75% of treated COVID-19 patients off ventilators

The Jerusalem Post, May 16, 2020

Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.

Israeli Life Sciences, May 14, 2020

Israel’s Pluristem FDA approved for study in treatment of severe COVID-19

The Jerusalem Post, May 08, 2020

Regenerating the body’s healing mechanisms for COVID-19 patients

Science Business, May 07, 2020

  Roundup: Israeli hi-tech firms focus on seeking solutions to COVID-19 challenges

Xinhua News Agency – China , May 06, 2020

Will placenta cells beat the corona? The Israeli treatment that intrigues the world (Hebrew)

Israeli Channel 12, May 2, 2020
For English subtitles click here

Fighting the Corona: First Agreement Between the EU and Israel (Hebrew)

Maariv, May 1, 2020

Lean, mean, cold-chain machine (page 60)

World Pharmaceutical Frontiers, May, 2020

European Investment Bank, Israel Innovation Authority Collaborate on Medical Investments

Calcalist, April 30, 2020

€50 loan from European Investment Bank to Israeli company Pluristem

Israel National News Channel 7, April 30, 2020

Stem cells from a baby’s placenta may save life of coronavirus victim in NJ

New York Post, April 13, 2020

Israeli COVID-19 treatment shows 100% survival rate – preliminary data

The Jerusalem Post, April 12, 2020

Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19

BioSpace, April 09, 2020

We are on it- main Israeli developments to deal with Covid-19 (Hebrew)

ידיעות אחרונות, April 03, 2020

Israeli company uses placenta cells to treat critical COVID-19 patients

The Jerusalem Post, March 30, 2020

Three Corona patients in Israel have been treated with Israeli placenta-based medicine (Hebrew)

The Marker, March 30, 2020

Israeli technological developments attempting to cope with the Covid_19 Coronavirus (Hebrew)

Israeli Channel 13, March 24, 2020

Israel to weigh “compassionate use” of Pluristem therapy for COVID-19

Reuters, March 17, 2020

Israeli cell therapy could treat respiratory effects caused by coronavirus

The Jerusalem Post, March 15, 2020

  Israeli cell therapy demand could be worth $2 billion by 2023

The Jerusalem Post, February 9, 2020

How Is Biotechnology Used In Space Exploration Missions?

Scientist Live, December 17, 2019

Pluristem Completes 75% Enrollment in its Pivotal Phase III CLI Clinical Study

The Wall Street Journal, December 17, 2019

Taking It All The Way To Phase 3 Clinical Trials

Life Science Leader, November 1, 2019

Holy Name clinical trial tests the healing power of stem cells

NJTV News, October 18, 2019

Positive results for radiation prophylaxis

DrugDiscoveryNews, October, 2019

Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs

Bloomberg, September 16, 2019

Pluristem gets positive results from radiation treatment trials

Reuters, July 31, 2019

Regenerative Medicine Companies Pursue Unique Regulatory Pathways

Applied Clinical Trials, July 09, 2019

JPost Israeli medicine company aims to manufacture cannabinoid-producing cells

The Jerusalem Post, May 8, 2019

NASA looks to Israeli biotech firm to solve long duration spaceflight 

Politico, May 03, 2019

  To Reach Mars, We Need Biotechnology 

Labiotech.eu, March 27, 2019

 The rise of regenerative medicine

News Channel 13, March 23, 2019

Stem cell therapies for space missions? Pluristem joins forces with NASA to combat space-related ailments

EndPoints News, February 20, 2019

Pluristem’s Point-Of-Care Thawing Device To Be Manufactured And Distributed By Chart Industries

Biobanking, December 17, 2018

Human placenta stem cells help people recover from hip surgery

New Scientist, October 17, 2018

IRMC patient receives historic stem cell surgery

The Indiana Gazette, September 23, 2018

Does the Placenta Hold the Answer to One of Our Most Challenging Medical Problems?

Bloomberg, September 10, 2018

Thermo Fisher, Pluristem partner to scale up regenerative cell therapy manufacturing

Fierce Bio Tech, July 9, 2018

Clinical trial at Holy Name aims to save limbs and lives

NJTV news, June 26, 2018

Study shows placenta treatment effective against radiation sickness

The Times of Israel, June 26, 2018

US DoD to study PLX-R18 cell therapy to treat mustard gas injuries

Army technology, June 21, 2018

Israel’s Pluristem sees positive results from leg pain study

Reuters, June 12, 2018

Pluristem Breakthrough Brings Global Hope for Radiation Treatment

Bloomberg, May 22, 2018

FDA clears Pluristem radiation treatment for emergency use

Reuters, April 30, 2018

Uma vacina contra radiacoes nucleares

Sic noticias, March 24, 2018 (Portuguese)

JPost Smart cells that heal

The Jerusalem Post, February 14, 2018

North Korea nuclear fears boost demand for survivalist gear, services

The Washington Times, February 01, 2018

North Korea threats spur U.S. search for new radiation therapies

Reuters, January 31, 2018

JPost New hope for cancer patients

The Jerusalem Post, January 12, 2018

gen Stem Cell Manufacturing: It’s All about Scale

GEN news, January 1, 2018

FDA clears expanded access programme for Pluristem’s PLX-PAD cell treatment

EPM magazine, January 10, 2018

Pluristem Gets Accelerated Approval Pathways in Top 3 Healthcare Markets – U.S., Europe, Japan

Bio Informant, December 7, 2017

JPost ‘It’s time to invest in cell-based treatment for nuclear exposure’ 

The Jerusalem Post, December 7, 2017

Pluristem’s innovative technology, cell therapy products and a potentially answer for radiation exposure

i24News (French), November 19, 2017

Trending 2018: Pipeline Disrupters

Pharma Voice, November 2017

Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHD

The New York Times, November 6, 2017

JPost Health Ministry approves pioneering placenta-cell therapy for blood disorders

Jerusalem Post, October 29, 2017

Die Welt (in German)

October 20, 2017

JPost Can the organ of life save lives?

Jerusalem Post, October 20, 2017

Pluristem Therapeutics (PSTI) Stock: Gaining On Orphan Drug Designation

CNA Finance, October 19, 2017

Cell Therapy for Chronic Disease

Drug Descovery & Development, October 18, 2017

BioSpace-logo New Published Data Highlights the Potential of Pluristem’s PLX Cells in Improving Cardiac Function in Diabetes

BioSpace, October 16, 2017

drug dev Pluristem: 3D Macrocarrier Bioreactor Technology Overcomes Limitations of 2D Microcarriers
Drug Development & Delivery, October issue 2017
U.S. FDA Grants Fast Track Designation to Pluristem’s PLX-PAD for the Treatment of CLI

BioInformant, September 18, 2017

Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regeneration

Market Insider, September 13, 2017

logo-globes-en Stem cell co Pluristem awarded $8.7m EU grant

Globes, September 6, 2017

US military testing radiation exposure drug

CNN, September 5, 2017

gen U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy Against ARS

GEN news, August 17, 2017

Surviving a Nuclear Attack

Real Clear Defense, August 4, 2017

energy voice Scientists find ‘cure’ for nuclear radiation exposure
 

Energy Voice, July 27, 2017

Seeking_Alpha_logo1 Pluristem’S Radiation Antidote Addresses $11 Billion Hematologic Indication In Human Trials

Seeking Alpha, July 23, 2017

marketwatch This new drug could help the U.S. survive a nuclear meltdown

Market Watch, July 18, 2017

JPost The Israeli company protecting against radiation catastrophe

Jerusalem Post, July 14, 2017

BioSpace-logo Pluristem Therapeutics (PSTI) Advances Its Multinational Phase III Critical Limb Ischemia Study

BioSpace, July 10, 2017

logo-globes-en The Health System Care in Israel-  A Reference to the OECD report (Hebrew)

Globes. July 3, 2017

fyi Critical Limb Ischemia- an unmet need

FYI News, June 2017

fyi Cell therapy – the next generation of biological therapeutic products

FYI News, June 2017

fyi Placental cell therapy

FYI News, June 2017

JPost  The Israeli company protecting against radiation catastrophe

Jerusalem Post, May 26, 2017

HSNW Pocket-size biological solution to radioactive threats

Homeland Security news wire, May 15, 2017

HSNW EXCLUSIVE: Are Governments Sufficiently Prepared for Nuclear Incidents?

Homeland Security Today, April 20, 2017

CNA-Finance-Logo1 Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?

CNA Finance, April 10, 2017

defense-news US Tests Potential Israeli Cure for Victims of ‘Nuclear Terrorism’

Defense News, March 30, 2017

drug dev CELL THERAPY – PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases

Drug Development, February 28, 2017

bio connection Regenerative Medicine for Effective, Non-Invasive Treatment of Critical Limb Ischemia

The Bio Connection, February 15, 2017

gen Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood Transplants

GEN news, December 27, 2016

gen Pluristem, Sosei Set Up in Japan to Commercialize Cell Therapy for CLI

GEN news, December 20, 2016

Seeking_Alpha_logo1 Phase III Cell Therapy Company Pluristem Gets $8 Million Grant For Pivotal Trial In $12 Billion CLI Market

Seeking Alpha, August 21, 2016

orthopedic Pluristem: Trial of PLX-PAD Cells for Femoral Neck Fracture

Orthopedics this week, August 11, 2016